Post COVID-19 Syndrome: A Literature Review

Abstract

The COVID-19 pandemic shook the entire world in January 2020 last year and is still posing a major threat to the entire humanity. A lot of studies have been conducted studying the diagnosis and management of the disease caused by this highly contagious virus, but less is known about the Post COVID-19 sequelae. There is very limited evidence about the management of COVID-19 after the first three weeks of illness. About 10% of the patients experience prolonged illness after COVID-19. Treatment is mainly focused on reassurance, self-care, and symptomatic control. There are currently no FDA-approved treatments specifically for this condition. Clinicians and researchers have focused on the acute phase of COVID-19, but continued monitoring after discharge for long-lasting effects is needed.